T. Rowe Price Associates’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,355
| Closed | -$242K | – | 3068 |
|
|
2024
Q1 | $242K | Buy |
15,355
+1,984
| +15% | +$31.3K | ﹤0.01% | 2530 |
|
|
2023
Q4 | $216K | Buy |
13,371
+1,624
| +14% | +$26.2K | ﹤0.01% | 2512 |
|
|
2023
Q3 | $150K | Buy |
11,747
+1,414
| +14% | +$18.1K | ﹤0.01% | 2571 |
|
|
2023
Q2 | $146K | Sell |
10,333
-589,342
| -98% | -$8.33M | ﹤0.01% | 2609 |
|
|
2023
Q1 | $9.27M | Sell |
599,675
-25,212
| -4% | -$390K | ﹤0.01% | 1072 |
|
|
2022
Q4 | $10.2M | Sell |
624,887
-91,870
| -13% | -$1.51M | ﹤0.01% | 1049 |
|
|
2022
Q3 | $13.3M | Buy |
716,757
+569,958
| +388% | +$10.5M | ﹤0.01% | 1011 |
|
|
2022
Q2 | $1.93M | Buy |
+146,799
| New | +$1.93M | ﹤0.01% | 1625 |
|
|
2022
Q1 | – | Sell |
-311,669
| Closed | -$3.05M | – | 3020 |
|
|
2021
Q4 | $3.05M | Sell |
311,669
-137,430
| -31% | -$1.34M | ﹤0.01% | 1578 |
|
|
2021
Q3 | $15.3M | Sell |
449,099
-70,177
| -14% | -$2.38M | ﹤0.01% | 1358 |
|
|
2021
Q2 | $19M | Sell |
519,276
-648,992
| -56% | -$23.8M | ﹤0.01% | 1310 |
|
|
2021
Q1 | $52.4M | Sell |
1,168,268
-6,624
| -0.6% | -$297K | 0.01% | 985 |
|
|
2020
Q4 | $67.1M | Sell |
1,174,892
-14,595
| -1% | -$833K | 0.01% | 852 |
|
|
2020
Q3 | $61M | Sell |
1,189,487
-349,213
| -23% | -$17.9M | 0.01% | 803 |
|
|
2020
Q2 | $91.9M | Buy |
1,538,700
+62,879
| +4% | +$3.76M | 0.01% | 660 |
|
|
2020
Q1 | $60.8M | Sell |
1,475,821
-215,648
| -13% | -$8.88M | 0.01% | 716 |
|
|
2019
Q4 | $105M | Buy |
1,691,469
+1,215,965
| +256% | +$75.7M | 0.01% | 651 |
|
|
2019
Q3 | $16.1M | Buy |
+475,504
| New | +$16.1M | ﹤0.01% | 1211 |
|